EGFR and neoplasm: In addition, a mask is fused to each of the EGFR and CD3 binding domains through tumor protease cleavable linkers, and only when the molecule enters the tumor site and is recognized by the tumor protease can the peptide masks be released, ultimately generating the active molecules (186).